Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elodie Anthony"'
Autor:
Elise Dumas, Beatriz Grandal, Paul Gougis, Sophie Houzard, Aurélien Latouche, Aullène Toussaint, Samar Alsafadi, Judith Abecassis, Lidia Delrieu, Thierry Dubois, Nadir Sella, Marc Espie, Bernard Asselain, Annabelle Ballesta, Benjamin Marande, Eric Daoud, Enora Laas, Amyn Kassara, Floriane Jochum, Elaine Del Nery, Elodie Anthony, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Chloé-Agathe Azencott, Fabien Reyal, Anne-Sophie Hamy
Publikováno v:
Cancer Research. 83:P3-07
Background: More than half of Breast Cancer (BC) patients take chronically used non-cancer treatments (denoted as comedications) at BC diagnosis. Epidemiological evidence has reported that several non-cancer treatments may modify BC risk, BC recurren
Autor:
Céline Chauvin, Amaury Leruste, Arnault Tauziede-Espariat, Mamy Andrianteranagna, Didier Surdez, Aurianne Lescure, Zhi-Yan Han, Elodie Anthony, Wilfrid Richer, Sylvain Baulande, Mylène Bohec, Sakina Zaidi, Marie-Ming Aynaud, Laetitia Maillot, Julien Masliah-Planchon, Stefano Cairo, Sergio Roman-Roman, Olivier Delattre, Elaine Del Nery, Franck Bourdeaut
Publikováno v:
Cell Reports, Vol 21, Iss 7, Pp 1737-1745 (2017)
Summary: Rhabdoid tumors (RTs) are aggressive tumors of early childhood characterized by SMARCB1 inactivation. Their poor prognosis highlights an urgent need to develop new therapies. Here, we performed a high-throughput screening of approved drugs a
Externí odkaz:
https://doaj.org/article/d423d349b9b14f909111a6ac8efab59a
Autor:
Alison Iroz, Alexandra Montagner, Fadila Benhamed, Françoise Levavasseur, Arnaud Polizzi, Elodie Anthony, Marion Régnier, Edwin Fouché, Céline Lukowicz, Michèle Cauzac, Emilie Tournier, Marcio Do-Cruzeiro, Martine Daujat-Chavanieu, Sabine Gerbal-Chalouin, Véronique Fauveau, Solenne Marmier, Anne-Françoise Burnol, Sandra Guilmeau, Yannick Lippi, Jean Girard, Walter Wahli, Renaud Dentin, Hervé Guillou, Catherine Postic
Publikováno v:
Cell Reports, Vol 21, Iss 2, Pp 403-416 (2017)
Summary: While the physiological benefits of the fibroblast growth factor 21 (FGF21) hepatokine are documented in response to fasting, little information is available on Fgf21 regulation in a glucose-overload context. We report that peroxisome-prolif
Externí odkaz:
https://doaj.org/article/27cfd3a0fbcd4dd49659cb793fec8873
Autor:
Elise Dumas, Beatriz Grandal, Lucie Laot, Eric Daoud, Lidia Delrieu, Marc Espié, Sophie Houzard, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Elodie Anthony, Aurélien Latouche, Nadir Sella, Thierry Dubois, Annabelle Ballesta, Amyn Kassara, Elaine Del Nery, Benjamin Marande, Samar Alsafadi, Paul Gougis, Chloé-Agathe Azencott, Fabien Reyal, Anne-Sophie Hamy
Publikováno v:
Cancer Research. 82:4101-4101
Background: Breast cancer (BC) incidence increases with age, as well as the incidence of many other chronic diseases. Between 42 and 68% of BC patients suffer from other chronic conditions -comorbidities- at BC diagnosis. Comorbidities may be associa
Autor:
Julie Charpentier, Ottavia Porzio, Josep Puig, Matteo Serino, Iris Cardolini, Richard H. Barton, Fabienne Foufelle, Marina Cardellini, Fadila Benhamed, José Manuel Fernández-Real, Massimo Federici, Marc-Emmanuel Dumas, Mark Woodbridge, Jeremy K. Nicholson, Julien Chilloux, Antonis Myridakis, Wifredo Ricart, Vincent Blasco-Baque, Paolo Gentileschi, Christopher Tomlinson, Christophe Heymes, Francesca Davato, Elaine Holmes, José María Moreno-Navarrete, Sarah Butcher, Gemma Xifra, Jèssica Latorre Luque, Rémy Burcelin, Lesley Hoyles, Catherine Postic, Vincent Azalbert, Elodie Anthony, Laura Martinez-Gili, James Abbott, Frédéric Lopez
Publikováno v:
Nature Medicine
Nature Medicine, 2018, 24 (10), pp.1628-1628. ⟨10.1038/s41591-018-0169-5⟩
Nature Medicine, Nature Publishing Group, 2018, 24 (10), pp.1628-1628. ⟨10.1038/s41591-018-0169-5⟩
Nature Medicine, 2018, 24 (10), pp.1628-1628. ⟨10.1038/s41591-018-0169-5⟩
Nature Medicine, Nature Publishing Group, 2018, 24 (10), pp.1628-1628. ⟨10.1038/s41591-018-0169-5⟩
In the version of this article originally published, the received date was missing. It should have been listed as 2 January 2018. The error has been corrected in the HTML and PDF versions of this article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b1fc11dad6ea6f713b828cecb48a8d1
https://hal.archives-ouvertes.fr/hal-03144734
https://hal.archives-ouvertes.fr/hal-03144734
Autor:
Jèssica Latorre Luque, Marina Cardellini, Marc-Emmanuel Dumas, Gemma Xifra, Francesca Davato, Josep Puig, Vincent Blasco-Baque, Iris Cardolini, Elodie Anthony, José Manuel Fernández-Real, Fadila Benhamed, Laura Martinez-Gili, Massimo Federici, Rémy Burcelin, Wifredo Ricart, Lesley Hoyles, Julie Charpentier, Catherine Postic, Richard H. Barton, Frédéric Lopez, José María Moreno-Navarrete, Sarah Butcher, Antonis Myridakis, Matteo Serino, James Abbott, Fabienne Foufelle, Vincent Azalbert, Paolo Gentileschi, Christopher Tomlinson, Julien Chilloux, Christophe Heymes, Mark Woodbridge, Elaine Holmes, Ottavia Porzio, Jeremy K. Nicholson
Publikováno v:
Nature Medicine
Nature Medicine, Nature Publishing Group, 2018, 24, pp.1070-1080. ⟨10.1038/s41591-018-0061-3⟩
Nature Medicine, Nature Publishing Group, 2018, 24 (7), pp.1070-1080. ⟨10.1038/s41591-018-0061-3⟩
Nature Medicine, 2018, 24 (7), pp.1070-1080. ⟨10.1038/s41591-018-0061-3⟩
Nature medicine
Nature Medicine, Nature Publishing Group, 2018, 24, pp.1070-1080. ⟨10.1038/s41591-018-0061-3⟩
Nature Medicine, Nature Publishing Group, 2018, 24 (7), pp.1070-1080. ⟨10.1038/s41591-018-0061-3⟩
Nature Medicine, 2018, 24 (7), pp.1070-1080. ⟨10.1038/s41591-018-0061-3⟩
Nature medicine
Hepatic steatosis is a multifactorial condition that is often observed in obese patients and is a prelude to non-alcoholic fatty liver disease. Here, we combine shotgun sequencing of fecal metagenomes with molecular phenomics (hepatic transcriptome a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0f5bc10166ab378b84a65b3472b5ef
https://irep.ntu.ac.uk/id/eprint/34314/1/11724_Hoyles.pdf
https://irep.ntu.ac.uk/id/eprint/34314/1/11724_Hoyles.pdf
Autor:
Elaine Del Nery, Stefano Cairo, Amaury Leruste, Zhi-Yan Han, Elodie Anthony, Franck Bourdeaut, Arnault Tauziède-Espariat, Marie-Ming Aynaud, Sergio Roman-Roman, Sakina Zaidi, Didier Surdez, Laetitia Maillot, Julien Masliah-Planchon, Aurianne Lescure, Wilfrid Richer, Olivier Delattre, Céline Chauvin
Publikováno v:
SSRN Electronic Journal.
The poor prognosis of rhabdoid tumors (RT) justifies the search for new therapies. By a high‐throughput drug screening and subsequent in vitro confirmation of selected drugs, we identified as good SMARCB1‐dependent therapeutic candidates, broad i
Autor:
Anne-Françoise Burnol, Arnaud Polizzi, Marcio Do-Cruzeiro, Hervé Guillou, Emilie Tournier, Alison Iroz, Céline Lukowicz, Walter Wahli, Edwin Fouché, Solenne Marmier, Jean Girard, Renaud Dentin, Catherine Postic, Elodie Anthony, Fadila Benhamed, Françoise Levavasseur, Marion Régnier, Martine Daujat-Chavanieu, Yannick Lippi, Sandra Guilmeau, Véronique Fauveau, Sabine Gerbal-Chalouin, Michele Cauzac, Alexandra Montagner
Publikováno v:
Cell Reports
Cell Reports, Elsevier Inc, 2017, 21 (2), pp.403-416. ⟨10.1016/j.celrep.2017.09.065⟩
Cell Reports 2 (21), 403-416. (2017)
Cell Reports, Vol 21, Iss 2, Pp 403-416 (2017)
Cell reports, vol. 21, no. 2, pp. 403-416
Cell Reports, Elsevier Inc, 2017, 21 (2), pp.403-416. ⟨10.1016/j.celrep.2017.09.065⟩
Cell Reports 2 (21), 403-416. (2017)
Cell Reports, Vol 21, Iss 2, Pp 403-416 (2017)
Cell reports, vol. 21, no. 2, pp. 403-416
Summary While the physiological benefits of the fibroblast growth factor 21 (FGF21) hepatokine are documented in response to fasting, little information is available on Fgf21 regulation in a glucose-overload context. We report that peroxisome-prolife
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2440405e9afebdd2072ecbfc3a0088
https://hal.umontpellier.fr/hal-01837159
https://hal.umontpellier.fr/hal-01837159
Autor:
Aurianne Lescure, Laetitia Maillot, Wilfrid Richer, Elodie Anthony, Sergio Roman-Roman, Céline Chauvin, Marie-Ming Aynaud, Franck Bourdeaut, Arnault Tauziède-Espariat, Amaury Leruste, Olivier Delattre, Sakina Zaidi, Didier Surdez, Mylène Bohec, Sylvain Baulande, Elaine Del Nery, Mamy Andrianteranagna, Stefano Cairo, Zhi-Yan Han, Julien Masliah-Planchon
Publikováno v:
Cell Reports, Vol 21, Iss 7, Pp 1737-1745 (2017)
Summary: Rhabdoid tumors (RTs) are aggressive tumors of early childhood characterized by SMARCB1 inactivation. Their poor prognosis highlights an urgent need to develop new therapies. Here, we performed a high-throughput screening of approved drugs a
Autor:
Jacques Camonis, Bruno Ragazzon, Frédéric Canal, Elaine Del Nery, Aurianne Lescure, Christine Perret, Franck Perez, Elodie Anthony
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2015, 15 (1), pp.1020. ⟨10.1186/s12885-015-2037-8⟩
BMC Cancer, 2015, 15 (1), pp.1020. ⟨10.1186/s12885-015-2037-8⟩
BMC Cancer, BioMed Central, 2015, 15 (1), pp.1020. 〈10.1186/s12885-015-2037-8〉
BMC Cancer, BioMed Central, 2015, 15 (1), pp.1020. ⟨10.1186/s12885-015-2037-8⟩
BMC Cancer, 2015, 15 (1), pp.1020. ⟨10.1186/s12885-015-2037-8⟩
BMC Cancer, BioMed Central, 2015, 15 (1), pp.1020. 〈10.1186/s12885-015-2037-8〉
Background Aberrant activation of the Wnt/β-catenin pathway is a major and frequent event in liver cancer, but inhibition of oncogenic β-catenin signaling has proven challenging. The identification of genes that are synthetically lethal in β-caten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a5f37ac8cf2f6dd18b55d0c7ba0378
https://www.hal.inserm.fr/inserm-01254133/file/12885_2015_Article_2037.pdf
https://www.hal.inserm.fr/inserm-01254133/file/12885_2015_Article_2037.pdf